No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ZVSA ZyVersa Therapeutics
- 5.3700
- +0.0900+1.70%
Close May 10 16:00 ET
- 5.2500
- -0.1200-2.23%
Post 16:34 ET
4.08MMarket Cap-20P/E (TTM)
5.4384High5.1600Low61.44KVolume5.1800Open5.2800Pre Close324.64KTurnover9.30%Turnover RatioLossP/E (Static)759.49KShares180.250052wk High0.37P/B3.55MFloat Cap4.440052wk Low--Dividend TTM660.78KShs Float8750.0000Historical High--Div YieldTTM5.27%Amplitude4.4400Historical Low5.2830Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CRVS, CTMX and NRXP Are Among Premarket Gainers
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
What's Going On With ZyVersa Stock?
ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for
ZyVersa Therapeutics Stock Jumps 8%
Express News | ZyVersa Therapeutics Shares Resume Trade Following Circuit Breaker Halt
ImmunityBio, Aquestive Therapeutics, Clever Leaves Holdings Among Healthcare Movers
Comments
$ZyVersa Therapeutics(ZVSA.US$ up today?
1
Lots of eyes watching this one. Here are the levels to watch.
Larger Image: tradingview.com...
$ZyVersa Therapeutics(ZVSA.US$
Larger Image: tradingview.com...
$ZyVersa Therapeutics(ZVSA.US$
$ZyVersa Therapeutics(ZVSA.US$
NEWS
ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease
This publication, authored by leading experts in inflammasome-mediated inflammation and neurology at University of Miami Miller School of Medicine, demonstrates that multiple inflammasome triggers (NLRP1 and pyrin) govern the inflammatory response in Alzheimer’s Disease (AD), an...
NEWS
ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer’s Disease
This publication, authored by leading experts in inflammasome-mediated inflammation and neurology at University of Miami Miller School of Medicine, demonstrates that multiple inflammasome triggers (NLRP1 and pyrin) govern the inflammatory response in Alzheimer’s Disease (AD), an...
$ZyVersa Therapeutics(ZVSA.US$ Nice 40% for my group 🙈.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
The Real Wojak : Moon market pump